IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.

TSXV:IBT - Post by User

IBEX Technologies Inc > Could Afford a dividend

<< Previous

Bullboard Posts

Next >>

Comment by nozzpackon Dec 21, 2021 9:12am

43 Views

Post# 34249814

RE:RE:Could Afford a dividend

Thank you.
I prefer to use cash for growth but realize that a dividend would do wonders for the share price.

However, if this niche is constrained in terms of acquisition opps, and we have significant organic growth within 2 years with the new DAO product, then the major shareholder might tip the hand towards a modest dividend, post year end , reflective of previous financial year profitability.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions